Search results - 24 results
Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.
(VIA), or Lugol’s iodine (VILI) or with a magnifying device (VIAM), the Pap smear and human papillomavirus testing with the high-risk probe of the Hybrid Capture-2 assay (HC2), were evaluated in 11 studies ...
Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
The recognition of a strong etiological relationship between infection with high-risk human papillomavirusses and cervical cancer has prompted research to develop and evaluate prophylactic and ...
IPAAC Rapport WP4: Cancer control policy interview survey
provision of structural budgets. Register-based collection of structured and validated data of lifestyles and interventions from electronic data sources in health care would be a key to evaluation and to ...
Chapter 10: HPV testing on cervical cancer specimens: which assay can be used in cervical cancer screening.
screening programmes need to know which HPV tests are credible and have evidence-based performance in primary screening. Systematic reviews have assessed which high-risk HPV DNA tests are sufficiently ...